[PDF][PDF] Prognostic factors in glioblastoma patients managed with radiotherapy combined with temozolomide

E Peponi, I Tourkantonis, I Tasiou, N Pavlidis… - J BUON, 2014 - jbuon.com
Purpose: No consensus on clinicopathologic prognostic factors that predict the outcome of
patients with newly diagnosed glioblastoma multiforme (GBM) managed with resection …

Personalized prognosis stratification of newly diagnosed glioblastoma applying a statistical decision tree model

K Conrad, R Löber-Handwerker, M Hazaymeh… - Journal of Neuro …, 2024 - Springer
Purpose Glioblastoma (GBM) is the most frequent glioma in adults with a high treatment
resistance resulting into limited survival. The individual prognosis varies depending on …

SU‐F‐R‐04: radiomics for survival prediction in glioblastoma (GBM)

H Zhang, J Molitoris, S Tan, I Giacomelli… - Medical …, 2016 - Wiley Online Library
Purpose: To develop a quantitative radiomics approach for survival prediction of
glioblastoma (GBM) patients treated with chemoradiotherapy (CRT). Methods: 28 GBM …

Optimizing management of the elderly patient with glioblastoma: Survival prediction online tool based on BC Cancer Registry real-world data

R Zhao, J Zeng, K DeVries, R Proulx… - Neuro-oncology …, 2022 - academic.oup.com
Background Glioblastoma (GBM) is associated with fatal outcomes and devastating
neurological presentations especially impacting the elderly. Management remains …

EPCO-15. Detecting histologic & clinical glioblastoma patterns of prognostic relevance

B Baheti, S Rai, S Innani, G Mehdiratta… - Neuro …, 2023 - academic.oup.com
BACKGROUND Glioblastoma is the most common adult primary brain tumor. Limited
improvement in patient prospects over the last 20 years reflects our limited disease …

[HTML][HTML] Temozolomide and bevacizumab induction before chemoradiotherapy in patients with bulky glioblastoma and/or with severe neurological impairment

I Darmon, MC Morisse, A Coutte, M Blonski… - Journal of …, 2017 - ncbi.nlm.nih.gov
Background. New approaches are needed for patients newly diagnosed with bulky
glioblastoma (GB) and/or with severe neurological impairment that cannot benefit from first …

Using Artificial Intelligence and Magnetic Resonance Imaging to Address Limitations in Response Assessment in Glioma

A Krauze - Oncology Insights, 2023 - mediterraneanjournals.com
Gliomas are rapidly progressive, neurologically devastating, nearly uniformly fatal brain
tumors. In WHO grade IV tumors like glioblastoma, the standard of care involves maximal …

Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placebo

BM Ellingson, LE Abrey, J Garcia, O Chinot… - Neuro …, 2018 - academic.oup.com
Background In the current study we used contrast-enhanced T1 subtraction maps to test
whether early changes in enhancing tumor volume are prognostic for overall survival (OS) in …

Rationally designed pharmacogenomic treatment using concurrent capecitabine and radiotherapy for glioblastoma; gene expression profiles associated with outcome

JM Grunda, J Fiveash, CA Palmer, A Cantor… - Clinical cancer …, 2010 - AACR
Purpose: Previous preclinical studies suggested that concurrent capecitabine and radiation
could be an effective new treatment modality for glioblastoma (GBM). In the current study, we …

Validation of a novel molecular RPA classification in glioblastoma (GBM-molRPA) treated with chemoradiation: a multi-institutional collaborative study

CW Wee, IH Kim, CK Park, JW Kim, YS Dho… - Radiotherapy and …, 2018 - Elsevier
Background and purpose A novel molecular recursive partitioning analysis classification has
recently been reported integrating the MGMT promoter methylation (MGMTmeth) and IDH1 …